🔍 Observations
Topline
- Revenue from operations grew 11.1% YoY (₹13,140 Cr → ₹14,601 Cr), driven by volume-led expansion across both segments; C&B outpaced B2B at 11.4% vs 7.2%.
- Q4FY26 revenue at ₹3,583 Cr grew 14.1% YoY over Q4FY25 (₹3,141 Cr), but declined 3.4% QoQ from Q3FY26 (₹3,710 Cr) — typical seasonal softness.
- Inter-segment eliminations narrowed significantly (₹303 Cr → ₹245 Cr), indicating reduced internal trade, with external revenue quality improving.
Bottomline
- PAT grew 17.9% YoY (₹2,096 Cr → ₹2,471 Cr), ahead of revenue growth — operating leverage is visible at scale.
- Exceptional items dropped sharply to ₹13.7 Cr (FY26) from ₹24.9 Cr (FY25), meaning clean earnings quality improved further.
- Effective tax rate held steady at ~25.4%, with minimal deferred tax drag — no tax-driven PAT distortion.
Margins
- EBITDA margin expanded 131 bps to 28.1% — raw material intensity stable, while employee and other expense leverage improved.
- PAT margin (consolidated) widened 98 bps to 16.93% — bottom-line efficiency compounding quietly.
- B2B segment EBIT margin: ₹529 Cr on ₹3,211 Cr revenue = 16.5% vs C&B at ₹3,546 Cr on ₹11,574 Cr = 30.6%; structural margin gap between segments is wide and persists.
Growth Trajectory
- Three-year PAT CAGR implied by FY25→FY26 base: 17.9% single-year step is strong; C&B segment profit grew 19% YoY, signaling consumer-facing pricing power is intact.
- OCF grew 24.1% YoY (₹2,287 Cr → ₹2,837 Cr), faster than PAT — cash conversion ratio improved to 1.15x from 1.09x.
- CWIP jumped from ₹129 Cr to ₹329 Cr — accelerating capex cycle signals capacity expansion ahead; sustaining margins through this investment phase is the key test.

🧮 Profit & Loss Statement

🧮 Balance Sheet

🧮 Cash Flows Statement

🟢 Green Flags
- OCF/FCF conversion is best-in-class: FCF of ₹2,244 Cr against PAT of ₹2,471 Cr = 90.8% conversion; cash earnings are real.
- C&B segment margin at 30.6% reflects pricing power in branded adhesives/construction chemicals — structurally defensible moat.
- Near-zero leverage: Total borrowings of ₹106 Cr against equity of ₹11,049 Cr; D/E at 0.01x — balance sheet is fortress-grade.
- Inventory efficiency improving: DIO fell from 46.9 days to 43.4 days — working capital optimization despite volume growth.
- ROE expanded to 22.83% (from 21.95%) without leverage — quality return, not financial engineering.
- Bonus share issuance (1:1, Sep 2025) signals board confidence; EPS adjusted to ₹24.07 (basic), still grew 17.9% YoY on restated basis.
- Current ratio at 2.38x with liquid investments of ₹3,920 Cr in current assets — short-term resilience is exceptional.
🔴 Red Flags
- DSO deteriorated to 54.5 days from 50.3 days — receivables grew ₹370 Cr vs revenue growth of ₹1,461 Cr; collections are not keeping pace with revenue scaling.
- Dividend payout ratio spiked to 89.3% (FY26) from 49% (FY25) — includes final + interim payout of ₹21.50/share; at this level, reinvestment capacity is being stretched.
- Financing outflow surged to ₹1,671 Cr (from ₹918 Cr in FY25) primarily on dividends (₹1,526 Cr total paid) — aggressive capital return could constrain future strategic flexibility.
- B2B segment growing slowly at 7.2% revenue, 8.2% profit — industrial adhesives/resins segment is not a growth engine; concentration risk if C&B momentum slows.
- Others segment turned loss-making at ₹(9.3) Cr EBIT vs ₹0.9 Cr in FY25 — NBFC operations and raw material sales are dilutive to consolidated margins.
- CWIP more than doubled to ₹329 Cr — capex acceleration without clear revenue visibility could pressure near-term FCF if utilisation lags.
- Goodwill + intangibles at ₹2,843 Cr = 18.4% of total assets — impairment risk warrants monitoring, especially with associates already flagged as exceptional items.
📊 Balance Sheet Analysis
- Asset-light growth: Total assets grew 10.1% to ₹15,433 Cr while equity grew 10.9% — asset efficiency maintained; equity multiplier stable at 1.40x.
- Liquid investment book of ₹3,920 Cr in current investments provides substantial hidden liquidity beyond reported cash of ₹232 Cr.
- Deferred tax liabilities (₹413 Cr) are material but stable — not a near-term cash risk; no aggressive tax structuring signals.
- Trade payables (₹1,537 Cr, DPO 99.7 days) are stretched — working capital funded partly by supplier credit; sustainable given Pidilite’s procurement scale, but bears watching.
💰 Cash Flow Analysis
- OCF of ₹2,837 Cr comfortably covered capex of ₹593 Cr and dividends of ₹1,526 Cr — cash generation is self-funding all capital allocation.
- Gross investment churn (purchases ₹6,388 Cr, proceeds ₹5,831 Cr) reflects active treasury management of liquid surplus, not operational capex — net investing outflow of ₹1,236 Cr is clean.
- Working capital consumed ₹43 Cr net (vs operating profit of ₹3,742 Cr pre-WC) — exceptional conversion; receivable buildup is the sole drag.
- Net cash declined ₹71 Cr to ₹218 Cr — but liquid investments grew ₹758 Cr to ₹3,920 Cr; headline cash decline is misleading.
💡 Investment Outlook
Pidilite enters FY27 with the strongest earnings quality it has demonstrated in recent years — 17.9% PAT growth, 28.1% EBITDA margins, near-zero debt, and 90%+ FCF conversion leave little structural to fault.
The core C&B franchise continues to compound ahead of top-line, with margin expansion suggesting operating leverage is real.
Key monitorables are the DSO deterioration (now above 54 days), a dividend payout that leaves thin reinvestment headroom, and whether the accelerating capex cycle (CWIP doubling) translates to revenue before it pressures FCF.
At current fundamentals, this is a high-quality compounder — the question is entirely one of valuation, not business quality.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial data, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.